16-88881326-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_005187.6(CBFA2T3):​c.1367G>A​(p.Arg456His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,433,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

CBFA2T3
NM_005187.6 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.56

Publications

1 publications found
Variant links:
Genes affected
CBFA2T3 (HGNC:1537): (CBFA2/RUNX1 partner transcriptional co-repressor 3) This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(16;21)(q24;q22) translocation is one of the less common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. This gene is also a putative breast tumor suppressor. Alternative splicing results in transcript variants. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03781855).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBFA2T3NM_005187.6 linkc.1367G>A p.Arg456His missense_variant Exon 9 of 12 ENST00000268679.9 NP_005178.4 O75081-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBFA2T3ENST00000268679.9 linkc.1367G>A p.Arg456His missense_variant Exon 9 of 12 1 NM_005187.6 ENSP00000268679.4 O75081-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.00000958
AC:
2
AN:
208744
AF XY:
0.0000174
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000188
AC:
27
AN:
1433840
Hom.:
0
Cov.:
32
AF XY:
0.0000225
AC XY:
16
AN XY:
710968
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32910
American (AMR)
AF:
0.00
AC:
0
AN:
42300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25478
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38722
South Asian (SAS)
AF:
0.000107
AC:
9
AN:
84036
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46234
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000164
AC:
18
AN:
1099270
Other (OTH)
AF:
0.00
AC:
0
AN:
59174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.0000296
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000170
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 25, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1367G>A (p.R456H) alteration is located in exon 9 (coding exon 9) of the CBFA2T3 gene. This alteration results from a G to A substitution at nucleotide position 1367, causing the arginine (R) at amino acid position 456 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
16
DANN
Benign
0.95
DEOGEN2
Benign
0.038
.;T;T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.78
T;T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.038
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.5
.;N;.
PhyloP100
1.6
PrimateAI
Benign
0.34
T
PROVEAN
Benign
1.5
N;N;N
REVEL
Benign
0.038
Sift
Benign
0.76
T;T;T
Sift4G
Benign
0.61
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.079
MutPred
0.20
.;Gain of glycosylation at S457 (P = 0.0779);.;
MVP
0.27
MPC
0.077
ClinPred
0.11
T
GERP RS
2.6
Varity_R
0.024
gMVP
0.24
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756757934; hg19: chr16-88947734; API